phenoxybenzamine hydrochloride
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- phenoxybenzamine hydrochloride
- Generic name
- PHENOXYBENZAMINE HYDROCHLORIDE
- Manufacturer
- Rising Pharma Holdings, Inc.
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 1d2108fa-4352-4f3f-9314-732ed8b6394c
- SPL ID
- 404d834f-4d6c-450f-b9cf-a83c357d0d12
- Version
- 1
- Effective date
- 2026-06-18
- Source export date
- 2026-09-28
- Source partition
- 14
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0014-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/db99fd80353afecef4949b48edcaa018be72b966b2360184251eb14df43743f9/drug-label-0014-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 06:41:37
| Harmonized routes |
|---|
| ORAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | ANDA | 204551 | derived:openfda.application_number |
| application number | ANDA204551 | openfda.application_number | |
| brand name | phenoxybenzamine hydrochloride | openfda.brand_name | |
| generic name | PHENOXYBENZAMINE HYDROCHLORIDE | openfda.generic_name | |
| manufacturer name | Rising Pharma Holdings, Inc. | openfda.manufacturer_name | |
| ndc | package | 16571-874-01 | openfda.package_ndc |
| ndc | product | 16571-874 | openfda.product_ndc |
| ndc11 | package | 16571087401 | derived:openfda.package_ndc |
| rxcui | 861402 | openfda.rxcui | |
| spl id | 404d834f-4d6c-450f-b9cf-a83c357d0d12 | id | |
| spl set id | 1d2108fa-4352-4f3f-9314-732ed8b6394c | set_id | |
| unii | X1IEG24OHL | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
WARNING Phenoxybenzamine hydrochloride-induced alpha -adrenergic blockade leaves beta -adrenergic receptors unopposed. Compounds that stimulate both types of receptors may, therefore, produce an exaggerated hypotensive response and tachycardia.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS The following adverse reactions have been observed, but there are insufficient data to support an estimate of their frequency. Autonomic Nervous System*: Postural hypotension, tachycardia, inhibition of ejaculation, nasal congestion, miosis. *These so-called "side effects" are actually evidence of adrenergic blockade and vary according to the degree of blockade. Miscellaneous: Gastrointestinal irritation, drowsiness, fatigue. To report SUSPECTED ADVERSE REACTIONS, contact Rising Pharma Holdings, Inc. at 1-844-874-7464 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.